P. Lecointe

657 total citations
24 papers, 548 citations indexed

About

P. Lecointe is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, P. Lecointe has authored 24 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Oncology and 6 papers in Pharmacology. Recurrent topics in P. Lecointe's work include Cancer therapeutics and mechanisms (13 papers), Cancer Treatment and Pharmacology (8 papers) and Pharmacogenetics and Drug Metabolism (6 papers). P. Lecointe is often cited by papers focused on Cancer therapeutics and mechanisms (13 papers), Cancer Treatment and Pharmacology (8 papers) and Pharmacogenetics and Drug Metabolism (6 papers). P. Lecointe collaborates with scholars based in France. P. Lecointe's co-authors include Claude Paoletti, P. Lesca, Daniel Mansuy, Jean-Pierre Macquet, Jean‐Luc Butour, André Moisand, Suzy Cros, David M. DeMarini, Abraham W. Hsie and Didier Pélaprat and has published in prestigious journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Biochemical Pharmacology.

In The Last Decade

P. Lecointe

23 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Lecointe France 13 351 218 169 117 105 24 548
H.W.S. King United Kingdom 14 423 1.2× 101 0.5× 95 0.6× 98 0.8× 269 2.6× 21 644
Robert P. Batzinger United States 7 357 1.0× 74 0.3× 130 0.8× 106 0.9× 154 1.5× 7 577
David J. Holbrook United States 14 316 0.9× 97 0.4× 59 0.3× 41 0.4× 83 0.8× 41 562
J.H.T.M. Ploemen Netherlands 15 547 1.6× 79 0.4× 133 0.8× 69 0.6× 40 0.4× 21 724
Robert A. Wiley United States 11 242 0.7× 69 0.3× 100 0.6× 168 1.4× 40 0.4× 40 495
Lucie Bořek-Dohalská Czechia 11 301 0.9× 180 0.8× 199 1.2× 74 0.6× 48 0.5× 25 505
Thomas J. Flammang United States 15 414 1.2× 69 0.3× 103 0.6× 56 0.5× 332 3.2× 23 696
G. Ramachandra Reddy United States 14 599 1.7× 78 0.4× 36 0.2× 104 0.9× 277 2.6× 17 858
Ronald G. Harvey United States 11 291 0.8× 56 0.3× 38 0.2× 110 0.9× 193 1.8× 19 464
J. L. Hartwell United States 13 191 0.5× 56 0.3× 48 0.3× 82 0.7× 56 0.5× 27 451

Countries citing papers authored by P. Lecointe

Since Specialization
Citations

This map shows the geographic impact of P. Lecointe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Lecointe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Lecointe more than expected).

Fields of papers citing papers by P. Lecointe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Lecointe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Lecointe. The network helps show where P. Lecointe may publish in the future.

Co-authorship network of co-authors of P. Lecointe

This figure shows the co-authorship network connecting the top 25 collaborators of P. Lecointe. A scholar is included among the top collaborators of P. Lecointe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Lecointe. P. Lecointe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Monsarrat, Bernard, et al.. (1985). Cytochrome P-450-mediated O-demethylation of two ellipticine derivatives. Differential effect of the murine Ah locus phenotype.. Drug Metabolism and Disposition. 13(4). 497–502. 4 indexed citations
2.
Lesca, P., et al.. (1984). A dual assay for the specific screening of 3-methylcholanthrene- and phenobarbital-like chemical inducers of cytochrome P-450 monooxygenases. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 129(3). 299–310. 10 indexed citations
3.
Lecointe, P.. (1984). Induction of the SFIA SOS repair function by psoralens in the dark. Mutation Research/DNA Repair Reports. 131(3-4). 111–113. 9 indexed citations
4.
DeMarini, David M., Suzy Cros, Claude Paoletti, P. Lecointe, & Abraham W. Hsie. (1983). Mutagenicity and cytotoxicity of five antitumor ellipticines in mammalian cells and their structure-activity relationships in Salmonella.. PubMed. 43(8). 3544–52. 35 indexed citations
5.
Lecointe, P., et al.. (1981). Metabolism of ethidium bromide in rats.. Drug Metabolism and Disposition. 9(2). 156–160. 3 indexed citations
6.
Lecointe, P., et al.. (1981). The hepatic metabolism of ethidium bromide to reactive mutagenic species: biochemical and structural requirements. Biochemical Pharmacology. 30(6). 601–609. 20 indexed citations
7.
Lesca, P., P. Lecointe, Didier Pélaprat, Claude Paoletti, & Daniel Mansuy. (1980). Structure-activity relationships in the inhibitory effects of ellipticines on benzo(a)pyrene hydroxylase activity and 3-methylcholanthrene mutagenicity. Biochemical Pharmacology. 29(24). 3231–3237. 28 indexed citations
8.
Lesca, P., P. Lecointe, Claude Paoletti, & Daniel Mansuy. (1979). Ellipticines as potent inhibitors of microsomes- dependent chemical mutagenesis. Chemico-Biological Interactions. 25(2-3). 279–287. 29 indexed citations
9.
Lesca, P., et al.. (1979). A class of strong inhibitors of microsomal monooxygenases: The elupticines. Chemico-Biological Interactions. 24(2). 189–197. 65 indexed citations
10.
Lecointe, P., Jean-Pierre Macquet, & Jean‐Luc Butour. (1979). Correlation between the toxicity of platinum drugs to L1210 leukaemia cells and their mutagenic properties. Biochemical and Biophysical Research Communications. 90(1). 209–213. 27 indexed citations
11.
Paoletti, Claude, P. Lecointe, P. Lesca, et al.. (1978). Metabolism of ellipticine and derivatives and its involvement in the antitumor action of these drugs. Biochimie. 60(9). 1003–1009. 19 indexed citations
12.
Lecointe, P., Jean-Pierre Macquet, & Jean‐Luc Butour. (1978). 19 Mutagenesis and induction of prophage Lambda by platinum compounds: comparison with in vitro effects on L1210 cells. Biochimie. 60(9). 1050–1050. 1 indexed citations
13.
Lecointe, P., P. Lesca, Suzy Cros, & Claude Paoletti. (1978). Some antitumor derivatives of ellipticine deprived of mutagenic properties. Chemico-Biological Interactions. 20(1). 113–121. 16 indexed citations
14.
Lesca, P., P. Lecointe, Claude Paoletti, & Daniel Mansuy. (1978). Ellipticines as potent inhibitors of drug metabolism. Protective effect against chemical mutagenesis and carcinogenesis. Biochimie. 60(9). 1011–1018. 11 indexed citations
15.
Lecointe, P., Jean-Pierre Macquet, Jean‐Luc Butour, & Claude Paoletti. (1977). Relative efficiencies of a series of square-planar platinum(II) compounds on Salmonella mutagenesis. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 48(2). 139–143. 70 indexed citations
16.
Lecointe, P., Mark D. Wright, & Alain Dedieu. (1977). Synthesis of a 125I-labelled derivative of the antibiotic griseofulvin.. The Journal of Antibiotics. 30(11). 965–968. 2 indexed citations
17.
Lesca, P., et al.. (1977). The hydroxylation of the antitumor agent, ellipticine, by liver microsomes from differently pretreated rats. Biochemical Pharmacology. 26(22). 2169–2173. 32 indexed citations
18.
Lesca, P., P. Lecointe, Claude Paoletti, & Daniel Mansuy. (1976). Induction des mono-oxygénases hépatiques par l'ellipticine chez le Rat: Formation de cytochrome P448. Activité hydroxylante. Comptes rendus hebdomadaires des séances de l Académie des sciences. 282(15). 4 indexed citations
19.
Lesca, P., P. Lecointe, Claude Paoletti, & Daniel Mansuy. (1976). [Induction of rat hepatic mono-oxygenases by ellipticine: formation of cytochrome p448. Hydroxylating activity].. PubMed. 282(15). 1457–60. 2 indexed citations
20.
CROS, S., et al.. (1975). Toxicological and pharmacological studies on 9-hydroxy-ellipticine in mice. Toxicology and Applied Pharmacology. 33(3). 484–497. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026